Williamson K. International experience of vedolizumab in primary sclerosis cholangitis and inflammatory bowel disease. PS-134.
Ceftolozaan-tazobactam versus ceftazidim-avibactam bij multiresistente P. aeruginosa
aug 2025 | Bacteriële infecties, Pneumonie